Eight Capital lowered shares of CannTrust (NYSE:CTST) from a buy rating to a neutral rating in a research note issued to investors on Monday, The Fly reports.

Other research analysts have also recently issued research reports about the company. Citigroup set a $95.00 target price on iRobot and gave the company a hold rating in a research note on Wednesday, July 3rd. Bloom Burton upgraded CannTrust from an accumulate rating to a buy rating in a report on Wednesday, May 15th. Bank of America reiterated a sell rating on shares of Deutsche Bank in a report on Monday. Paradigm Capital reissued a buy rating on shares of CannTrust in a research report on Thursday, May 23rd. Finally, BMO Capital Markets raised Tourmaline Oil from a market perform rating to an outperform rating in a research report on Thursday, May 30th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the stock. The company presently has an average rating of Buy and an average target price of C$7.94.

CTST stock traded down C$0.15 on Monday, reaching C$3.01. 536,979 shares of the company traded hands, compared to its average volume of 2,200,430. The company has a market cap of $697.64 million, a P/E ratio of -27.27 and a beta of 3.51. The firm’s fifty day simple moving average is C$5.13. CannTrust has a one year low of C$3.08 and a one year high of C$11.97. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.38 and a current ratio of 5.64.

CannTrust (NYSE:CTST) last announced its quarterly earnings data on Tuesday, May 14th. The company reported C$0.09 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of C($0.05) by C$0.14. CannTrust had a negative return on equity of 6.69% and a negative net margin of 22.33%. The business had revenue of C$16.85 million for the quarter, compared to the consensus estimate of C$17.00 million. During the same period in the previous year, the business earned $0.12 earnings per share. The business’s revenue was up 114.9% on a year-over-year basis.

Several institutional investors have recently added to or reduced their stakes in CTST. PNC Financial Services Group Inc. acquired a new position in CannTrust in the first quarter valued at $26,000. Shell Asset Management Co. purchased a new stake in shares of CannTrust in the first quarter valued at about $41,000. Paragon Capital Management LLC purchased a new stake in shares of CannTrust in the first quarter valued at about $54,000. Winslow Evans & Crocker Inc. purchased a new position in shares of CannTrust during the first quarter valued at approximately $56,000. Finally, K.J. Harrison & Partners Inc purchased a new position in shares of CannTrust during the first quarter valued at approximately $100,000. 5.96% of the stock is owned by institutional investors and hedge funds.

CannTrust Company Profile

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Further Reading: Stop Order Uses For Individual Investors

The Fly

Analyst Recommendations for CannTrust (NYSE:CTST)

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.